|Day's Range||73.00 - 73.97|
|52 Week Range||62.70 - 85.52|
|PE Ratio (TTM)||17.45|
|Dividend & Yield||1.85 (2.52%)|
|1y Target Est||N/A|
Like its rivals Cardinal Health (No. 7) and McKesson (No. 73), Amerisource has been buffeted by Wall Street’s concerns about pricing pressure on branded and generic drugs. SEE THE FULL LIST OF THE BARRON’S 500 Amerisource (ABC) “is a key cog within the pharmaceutical industry, as many other supply-chain participants are dependent upon its services for streamlined product distribution and procurement,” notes Vishnu Lekraj, a Morningstar analyst. Sales growth, as it happens, is one of three components in our annual ranking, which spotlights companies that do the best job of boosting revenue and investing for growth.
Jim Cramer discusses the rebound and also mentions the best tech story that no one knows about.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cardinal Health, Inc. Here are 5 ETFs with the largest exposure to CAH-US. Comparing the performance and risk of Cardinal Health, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)